EMAIL THIS PAGE TO A FRIEND

PloS one

EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.


PMID 25198428

Abstract

TRAIL is a death receptor ligand that induces cell death preferentially in tumor cells. Recombinant soluble TRAIL, however, performs poorly as an anti-cancer therapeutic because oligomerization is required for potent biological activity. We previously generated a diabody format of tumor-targeted TRAIL termed Db(αEGFR-sc)TRAIL, comprising single-stranded TRAIL molecules (scTRAIL) and the variable domains of a humanized variant of the EGFR blocking antibody Cetuximab. Here we define the bioactivity of Db(αEGFR)-scTRAIL with regard to both EGFR inhibition and TRAIL receptor activation in 3D cultures of Caco-2 colorectal cancer cells, which express wild-type K-Ras. Compared with conventional 2D cultures, Caco-2 cells displayed strongly enhanced sensitivity toward Db(αEGFR)-scTRAIL in these 3D cultures. We show that the antibody moiety of Db(αEGFR-sc)TRAIL not only efficiently competed with ligand-induced EGFR function, but also determined the apoptotic response by specifically directing Db(αEGFR)-scTRAIL to EGFR-positive cells. To address how aberrantly activated K-Ras, which leads to Cetuximab resistance, affects Db(αEGFR-sc)TRAIL sensitivity, we generated stable Caco-2tet cells inducibly expressing oncogenic K-Ras(G12V). In the presence of doxycycline, these cells showed increased resistance to Db(αEGFR-sc)TRAIL, associated with the elevated expression of the anti-apoptotic proteins cIAP2, Bcl-xL and FlipS. Co-treatment of cells with the Smac mimetic SM83 restored the Db(αEGFR)-scTRAIL-induced apoptotic response. Importantly, this synergy between Db(αEGFR)-scTRAIL and SM83 also translated to 3D cultures of oncogenic K-Ras expressing HCT-116 and LoVo colorectal cancer cells. Our findings thus support the notion that Db(αEGFR)-scTRAIL therapy in combination with apoptosis-sensitizing agents may be promising for the treatment of EGFR-positive colorectal cancers, independently of their KRAS status.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B9304 Anti-Bcl-x antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3500349
Anti-Bcl-xL antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
AV02008
Anti-BCL2L1 antibody produced in rabbit, affinity isolated antibody
AV30475
Anti-BCL2L1 antibody produced in rabbit, IgG fraction of antiserum
SAB2103893
Anti-BCL2L1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
HPA005513
Anti-BIRC2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401012
Anti-BIRC2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA002317
Anti-BIRC3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401013
Anti-BIRC3 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB3500428
Anti-DR4 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
D3938
Anti-DR5 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3500427
Anti-DR5 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1405964
Anti-HRAS antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV02065
Anti-TNFRSF10A antibody produced in rabbit, IgG fraction of antiserum
HPA054475
Anti-TNFRSF10A antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA023625
Anti-TNFRSF10B antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2102489
Anti-TNFRSF10B antibody produced in rabbit, affinity isolated antibody
WH0056616M2
Monoclonal Anti-DIABLO antibody produced in mouse, clone 4F9, purified immunoglobulin, buffered aqueous solution
SAB1405189 Monoclonal Anti-DIABLO antibody produced in mouse, clone 4F9, ascites fluid
SAB4100537
Monoclonal Anti-HRAS antibody produced in mouse, clone HRAS-A485, culture supernatant